Literature DB >> 19137209

Sharpening the focus on occupational safety and health in nanotechnology.

Paul Schulte1, Charles Geraci, Ralph Zumwalde, Mark Hoover, Vincent Castranova, Eileen Kuempel, Vladimir Murashov, Harri Vainio, Kai Savolainen.   

Abstract

Increasing numbers of workers are involved with the production, use, distribution, and disposal of nanomaterials. At the same time, there is a growing number of reports of adverse biological effects of engineered nanoparticles in test systems. It is useful, at this juncture, to identify critical questions that will help address knowledge gaps concerning the potential occupational hazards of these materials. The questions address (i) hazard classification of engineered nanoparticles, (ii) exposure metrics, (iii) the actual exposures to the different engineered nanoparticles in the workplace, (iv) the limits of engineering controls and personal protective equipment with respect to engineered nanoparticles, (v) the kinds of surveillance programs that may be required at workplaces to protect potentially exposed workers, (vi) whether exposure registers should be established for workers potentially exposed to engineered nanoparticles, and, (vii) whether engineered nanoparticles should be treated as "new" substances and evaluated for safety and hazards?

Mesh:

Substances:

Year:  2008        PMID: 19137209     DOI: 10.5271/sjweh.1292

Source DB:  PubMed          Journal:  Scand J Work Environ Health        ISSN: 0355-3140            Impact factor:   5.024


  2 in total

1.  Nanotechnology and exposure science: what is needed to fill the research and data gaps for consumer products.

Authors:  Paul J Lioy; Yevgen Nazarenko; Tae Won Han; Mary Jean Lioy; Gediminas Mainelis
Journal:  Int J Occup Environ Health       Date:  2010 Oct-Dec

2.  Impairment of coronary arteriolar endothelium-dependent dilation after multi-walled carbon nanotube inhalation: a time-course study.

Authors:  Phoebe A Stapleton; Valerie C Minarchick; Amy M Cumpston; Walter McKinney; Bean T Chen; Tina M Sager; David G Frazer; Robert R Mercer; James Scabilloni; Michael E Andrew; Vincent Castranova; Timothy R Nurkiewicz
Journal:  Int J Mol Sci       Date:  2012-10-24       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.